Joint Formulary & PAD

Pneumococcal polysaccharide vaccine - Immunisation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Intramuscular injection (IM)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pneumococcal polysaccharide vaccine
Indication :
Immunisation
Group Name :
Keywords :
Penumococcal vaccine, PPV-23, Streptococcus pneumoniae, pneumococcus infection
Brand Names Include :
Pneumovax 23
Important Information :

Pneumococcal immunisation: Pneumovax 23 (PPV23) has been replaced by Prevenar 20 (PCV20) for the national immunisation schemes (over 65s) and at risk patient groups. Remaining stocks of Pneumovax 23 may be used until depleted.

Refer to national resources:

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.